Linked from

The 54 pages that link to Rheumatoid arthritis, each with the reason it gives.

• MethotrexateRelated: Low-dose weekly methotrexate is a standard disease-modifying treatment.

• PrednisoneRelated: Prednisone can rapidly control inflammation while longer-term treatments take effect.

• Interleukin 6Related: IL-6 contributes to inflammation and systemic symptoms in this disease.

• Carpal tunnel syndromeRelated: Wrist inflammation can reduce available space within the carpal tunnel.

• Tumor necrosis factorRelated: TNF blockade can reduce joint inflammation and damage in this disease.

• CelecoxibRelated: Celecoxib may relieve symptoms but does not stop the underlying autoimmune disease.

• Pulmonary fibrosisRelated: It can involve the lungs and cause interstitial disease with fibrosis.

• AzathioprineRelated: Azathioprine has been used as a disease-modifying treatment, though other therapies are now often preferred.

• TocilizumabRelated: Tocilizumab is used when rheumatoid arthritis remains active despite other treatments.

• DiclofenacRelated: Diclofenac can reduce its pain and inflammation but does not stop the underlying disease process.

• Erythrocyte sedimentation rateRelated: ESR can help track inflammatory activity, though it cannot diagnose rheumatoid arthritis by itself.

• Metacarpophalangeal jointRelated: It commonly inflames the metacarpophalangeal joints and can deform the fingers.

• InfliximabRelated: Infliximab is used with methotrexate to reduce disease activity and joint damage.

• NaproxenRelated: Naproxen can reduce symptoms, though it does not stop the underlying disease process.

• Trigger fingerRelated: Inflammatory tendon-sheath disease can contribute to catching and finger dysfunction.

• ChloroquineRelated: Chloroquine has been used as a disease-modifying treatment, though safer alternatives are often favored.

• CortisoneRelated: Corticosteroids can temporarily control inflammation during active disease.

• BetamethasoneRelated: Systemic glucocorticoids such as betamethasone may be used in selected cases to control inflammation.

• Edward Calvin KendallRelated: Early cortisone treatment produced striking improvements in patients with this disease.

• James CoburnRelated: Coburn lived with rheumatoid arthritis for decades and spoke publicly about its effects.

• Kathleen TurnerRelated: Turner has spoken publicly about performing through the disease and its treatment.

• MethylprednisoloneRelated: Methylprednisolone may reduce inflammation during severe flares or as bridging treatment.

• PrednisoloneRelated: Prednisolone may provide short-term control while longer-term therapies take effect.

• Bronchiolitis obliteransRelated: This autoimmune disease is among the conditions associated with bronchiolitis obliterans.

• MeloxicamRelated: Meloxicam can relieve joint symptoms but does not stop the underlying autoimmune disease.

• CiclosporinRelated: Ciclosporin has been used as a disease-modifying treatment, though other drugs are now often preferred.

• Connective tissue cellsRelated: Synovial fibroblasts and immune cells sustain inflammation and tissue destruction in affected joints.

• IndometacinRelated: Indometacin can ease its symptoms but does not stop the underlying immune damage.

• PiroxicamRelated: Piroxicam may reduce rheumatoid arthritis symptoms, but it does not control the underlying autoimmune disease.

• PolyarthritisRelated: It is a common persistent cause of polyarthritis and can damage joints without treatment.

• Tadeusz ReichsteinRelated: Cortisone’s clinical effects in this disease brought adrenal hormone research into medical practice.